Skip to content
Menu
  • Journey
  • Partnership
  • Resources
  • Portfolio
    • RHA® Collection
    • DaxibotulinumtoxinA
    • OPUL
    • RevanceU
RevanceAesthetics logo
  • Journey
  • Partnership
  • Portfolio
      RHA Collection of HA fillers logo
      Filler Technology

      DaxibotulinumtoxinA

      Neuromodulator
      Relational Commerce
      Premier Training
RESOURCES
Uncategorized

Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 2

Byallen October 5, 2021October 5, 2021

Post navigation

Previous Previous
Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection
NextContinue
Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 3

Similar Posts

Uncategorized

Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection

Byallen October 5, 2021October 5, 2021

Read More Revance Receives FDA Approval for DaxibotulinumtoxinA for InjectionContinue

Uncategorized

Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 3

Byallen October 5, 2021October 5, 2021

Read More Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 3Continue

Uncategorized

Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 4

Byallen October 5, 2021October 5, 2021

Read More Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 4Continue

Uncategorized

Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 4

ByBrandon Hahr October 14, 2021October 14, 2021

Read More Revance Receives FDA Approval for DaxibotulinumtoxinA for Injection 4Continue

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RHA® Collection Indications and Important Safety Information
The RHA® Collection of resilient hyaluronic acid (HA) fillers includes RHA® 2, RHA® 3 and RHA® 4. RHA® 2 and RHA® 3 are indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds; and RHA® 4 is indicated for injection in the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds; in adults 22 or older.

Contraindications
Do not use in patients who have severe allergies, marked by a history of anaphylaxis or multiple severe allergies, or in patients with a history of allergies to gram-positive bacterial proteins or local anesthetics of the amide type, such as lidocaine. Do not use in patients with bleeding disorders.

Warnings
Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur. Product use at specific sites in which an active inflammatory process or infection is present should be deferred until the underlying process has been controlled.

Precautions
These products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy.
Discuss the potential risks of soft-tissue injections with your patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications.
The safety and effectiveness for the treatment of anatomic regions other than the labeled indications have not been established in controlled U.S. clinical studies.
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Standard precautions associated with injectable materials should be followed.
The safety for use in sites in the presence of other implants, during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied.
Use with caution in patients on immunosuppressive therapy.
Patients who are using products that can prolong bleeding (such as thrombolytics, anticoagulants, or inhibitors of platelet aggregation) may experience increased bruising or bleeding at treatment sites.
Patients with a history of herpetic eruptions may experience reactivation of the herpes.
There is a possible risk of inflammation at the implant site if laser treatments or a chemical peel are performed after treatment.
Use as supplied. Modification or use of the product outside the Directions for Use may adversely impact the sterility, safety, homogeneity, or performance of the product.
For single patient use. Do not reuse a syringe between two treatments and/or between two patients. Do not resterilize.

Adverse Events
The most commonly reported side effects were firmness, redness, tenderness, swelling, lumps/bumps, bruising, discoloration, pain, and itching. Most of these events were mild or moderate and resolved within 14 days. To report an adverse reaction with any RHA® product, please call Revance at (877) 373-8669.

DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA and is currently under regulatory review.

Corporate

  • About
  • Company
  • Investors

Revance aesthetics

  • Journey
  • Partnerships
  • Resources

Portfolio

  • RHA® Collection
  • DaxibotulinumtoxinA
  • OPUL
  • Revanceu

Contact us

  • Support@revance.com
  • 877-3REV-NOW
Facebook-f Instagram Twitter Linkedin-in
INTRIGUED?
Portfolio
RHA® Collection
DaxibotulinumtoxinA
OPUL™
RevanceU
Contact Us
support@revance.com
877-3REV-NOW
RevanceAesthetics logo

©2021 Revance Aesthetics. Revance Therapeutics and the Revance logo are registered trademarks of Revance Therapeutics, Inc. RHA® is a registered trademark of TEOXANE SA. All OTHER trademarks are the property of their respective ownerS.

  • Privacy Policy
  • Terms of use

RHA® Collection INDICATIONS and IMPORTANT SAFETY INFORMATION
The RHA® Collection of resilient hyaluronic acid (HA) fillers includes RHA® 2, RHA® 3 and RHA® 4. RHA® 2 and RHA® 3 are indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds; and RHA® 4 is indicated for injection in the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds; in adults 22 or older. READ MORE

We use cookies to personalize content, provide social media features, show you ads on other websites, and analyze site usage. You agree to the use of all cookies and the sharing of your information with third parties by clicking “Accept All.”
Manage My CookiesACCEPT ALL
Manage consent

Privacy Overview

Cookies are small text files that are placed on your computer by websites that you visit. They are widely used to make websites work or work more efficiently and to provide information to the site owners. Those cookies are called first-party cookies. We also use third party cookies – which are cookies from a domain different than the domain of the website you are visiting. We may use third party cookies to provide additional functionality and services, including enabling our marketing activity. Third party cookies are provided by third party providers we have engaged to provide these services.

We classify the cookies we use on this Website in the following categories, and you can change the setting on each cookie category (except for necessary cookies) below:
Necessary
Always Enabled
These cookies enable core functionality such as security, network management, and accessibility. These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site may not work.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Analytics
These cookies allow us to count visits and traffic sources, so we can measure and improve the performance of our site. They may be set by us or by third party providers whose services we have added to our pages. They help us know which pages are the most and least popular and see how visitors move around the site. If you do not allow these cookies, we will not know when you have visited our site.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_UA-165290226-71 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Advertisement
These cookies may be set, when enabled by you, by our advertising partners and store identifiers such as an Ad ID that uniquely identify your browser and internet device. The information in the cookie will be sent to these companies who may use it to build a profile of your interests and show you relevant advertising on other sites. If you do not allow these cookies, you will experience less personalized advertising.
CookieDurationDescription
NID6 monthsThis cookie is used to a profile based on user's interest and display personalized ads to the users.
Save & Accept